Predictors of Adverse Outcomes in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy: A Meta-Analysis of Observational Studies.


Journal

Cardiology in review
ISSN: 1538-4683
Titre abrégé: Cardiol Rev
Pays: United States
ID NLM: 9304686

Informations de publication

Date de publication:
Historique:
entrez: 11 6 2019
pubmed: 11 6 2019
medline: 18 12 2019
Statut: ppublish

Résumé

Arrhythmogenic cardiomyopathy (AC) is a hereditary disorder characterized by degeneration of cardiac myocytes and their subsequent replacement by fat and fibrous tissue primarily in the right ventricle. Our study aimed to systematically evaluate the impact of significant demographic, clinical, electrocardiographic, and echocardiographic factors in arrhythmic events in AC patients. MEDLINE and Cochrane library databases were manually searched without year or language restriction or any other limits until July 31, 2017. A pooled odds ratio with 95% confidence intervals was calculated for each of the risk factors. Our search retrieved 26 studies (n = 2680 patients, mean age: 37.9 years old, males: 51.9%) which were included in the quantitative synthesis. The most reliable predicting factors/parameters are the following: (1) male gender, (2) presyncope, (3) left ventricular dysfunction, (4) T-wave inversions in inferior leads, (5) proband status, (6) late potentials, (7) syncope, (8) inducibility at electrophysiological study, (9) right ventricular dysfunction, (10) epsilon waves, and (11) premature ventricular contractions greater than 1000/24 h. On the contrary, family history of sudden cardiac death, palpitations, premature ventricular contractions greater than 500/24 h, and T-wave inversions in right precordial leads fail to determine the outcome in this meta-analysis. In conclusion, multiple risk factors have been associated with arrhythmic events in AC patients. However, larger studies are needed to discriminate those patients who will benefit from implantable cardioverter defibrillators.

Identifiants

pubmed: 31180938
doi: 10.1097/CRD.0000000000000220
pii: 00045415-201907000-00005
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-197

Auteurs

George Bazoukis (G)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Konstantinos P Letsas (KP)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Costas Thomopoulos (C)

Department of Cardiology, Helena Venizelou Hospital, Athens, Greece.

Gary Tse (G)

Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, P.R. China and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, P.R. China.

Panagiotis Korantzopoulos (P)

First Department of Cardiology.

Katerina K Naka (KK)

Second Department of Cardiology, University of Ioannina, School of Medicine, Ioannina, Greece.

Vassiliki Kalfakakou (V)

Laboratory of Physiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Konstantinos Vlachos (K)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Xenophon Bazoukis (X)

Department of Cardiology, 'G. Hatzikosta' General Hospital, Ioannina, Greece.

Stamatis S Papadatos (SS)

Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Sotiria General Hospital of Athens, Greece.

Paschalia Michelongona (P)

NIMITS, Military Hospital, Athens, Greece.

Athanasios Saplaouras (A)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Stamatis Georgopoulos (S)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Nikolaos Karamichalakis (N)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Dimitris Asvestas (D)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Tong Liu (T)

Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, People's Republic of China.

Michael Efremidis (M)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Antonios Sideris (A)

From the Department of Cardiology, Cardiac Electrophysiology Laboratory, Evangelismos General Hospital of Athens, Athens, Greece.

Costas Tsioufis (C)

First Cardiology Clinic, Hippokration Hospital, University of Athens, Athens, Greece.

Adrian Baranchuk (A)

Division of Cardiology, Electrophysiology and Pacing, Queen's University, Kingston General Hospital, Kingston, Ontario, Canada.

Stavros Stavrakis (S)

Department of Medicine, Cardiovascular Section, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH